A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of [14C] BMS-986166 in Healthy Male Participants

The purpose of this study is to assess the drug levels of BMS-986166 in healthy male participants.

Inclusion Criteria:

• Healthy male participants as determined by no clinically significant deviation from normal in medical history, physical examination, 12-lead ECGs, or clinical laboratory determinations
• Body mass index between 18.0 to 33.0 kg/m2 (inclusive)

Exclusion Criteria:

• Any significant acute or chronic medical illness
• Current or recent history of constipation or irregular bowel movement (less than 1 bowel movement per day within the last 1 week)
• History of allergy (such as rash, hives, breathing difficulties) to any medications, either prescription or nonprescription

Other protocol-defined inclusion/exclusion criteria apply